Kefir Peptides Prevent Hyperlipidemia and Obesity in High-Fat-Diet-Induced Obese Rats via Lipid Metabolism Modulation

Yu Tang Tung, Hsiao Ling Chen, Hsin Shan Wu, Mei Hsuan Ho, Kowit Yu Chong, Chuan Mu Chen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Scope: Obesity has reached epidemic proportions worldwide. Obesity is a complex metabolic disorder that is linked to numerous serious health complications with high morbidity. The present study evaluated the effects of kefir peptides on high fat diet (HFD)-induced obesity in rats. Methods and results: Kefir peptides markedly improved obesity, including body weight gain, inflammatory reactions and the formation of adipose tissue fat deposits around the epididymis and kidney, and adipocyte size. Treating high fat diet (HFD)-induced obese rats with kefir peptides significantly reduced the fatty acid synthase protein and increased the p-acetyl-CoA carboxylase protein to block lipogenesis in the livers. Kefir peptides also increased fatty acid oxidation by increasing the protein expressions of phosphorylated AMP-activated protein kinase, peroxisome proliferator-activated receptor-α, and hepatic carnitine palmitoyltransferase-1 in the livers. In addition, administration of kefir peptides significantly decreased the inflammatory response (TNF-α, IL-1β, and TGF-β) to modulate oxidative damage. Conclusion: These results demonstrate that kefir peptides treatment improves obesity via inhibition of lipogenesis, modulation of oxidative damage, and stimulation of lipid oxidation. Therefore, kefir peptides may act as an anti-obesity agent to prevent body fat accumulation and obesity-related metabolic diseases.

Original languageEnglish
Article number1700505
JournalMolecular Nutrition and Food Research
Volume62
Issue number3
DOIs
Publication statusPublished - Feb 1 2018

Fingerprint

kefir
High Fat Diet
hyperlipidemia
high fat diet
Hyperlipidemias
Lipid Metabolism
lipid metabolism
obesity
Obesity
peptides
Peptides
rats
Lipogenesis
lipogenesis
metabolic diseases
liver
Adipose Tissue
Liver
Anti-Obesity Agents
Carnitine O-Palmitoyltransferase

Keywords

  • high fat diet (HFD)
  • kefir peptides
  • lipid oxidative pathway
  • lipogenesis
  • obesity
  • oxidative damage

ASJC Scopus subject areas

  • Biotechnology
  • Food Science

Cite this

Kefir Peptides Prevent Hyperlipidemia and Obesity in High-Fat-Diet-Induced Obese Rats via Lipid Metabolism Modulation. / Tung, Yu Tang; Chen, Hsiao Ling; Wu, Hsin Shan; Ho, Mei Hsuan; Chong, Kowit Yu; Chen, Chuan Mu.

In: Molecular Nutrition and Food Research, Vol. 62, No. 3, 1700505, 01.02.2018.

Research output: Contribution to journalArticle

Tung, Yu Tang ; Chen, Hsiao Ling ; Wu, Hsin Shan ; Ho, Mei Hsuan ; Chong, Kowit Yu ; Chen, Chuan Mu. / Kefir Peptides Prevent Hyperlipidemia and Obesity in High-Fat-Diet-Induced Obese Rats via Lipid Metabolism Modulation. In: Molecular Nutrition and Food Research. 2018 ; Vol. 62, No. 3.
@article{2d725030c9864aa79717a1b8444389b2,
title = "Kefir Peptides Prevent Hyperlipidemia and Obesity in High-Fat-Diet-Induced Obese Rats via Lipid Metabolism Modulation",
abstract = "Scope: Obesity has reached epidemic proportions worldwide. Obesity is a complex metabolic disorder that is linked to numerous serious health complications with high morbidity. The present study evaluated the effects of kefir peptides on high fat diet (HFD)-induced obesity in rats. Methods and results: Kefir peptides markedly improved obesity, including body weight gain, inflammatory reactions and the formation of adipose tissue fat deposits around the epididymis and kidney, and adipocyte size. Treating high fat diet (HFD)-induced obese rats with kefir peptides significantly reduced the fatty acid synthase protein and increased the p-acetyl-CoA carboxylase protein to block lipogenesis in the livers. Kefir peptides also increased fatty acid oxidation by increasing the protein expressions of phosphorylated AMP-activated protein kinase, peroxisome proliferator-activated receptor-α, and hepatic carnitine palmitoyltransferase-1 in the livers. In addition, administration of kefir peptides significantly decreased the inflammatory response (TNF-α, IL-1β, and TGF-β) to modulate oxidative damage. Conclusion: These results demonstrate that kefir peptides treatment improves obesity via inhibition of lipogenesis, modulation of oxidative damage, and stimulation of lipid oxidation. Therefore, kefir peptides may act as an anti-obesity agent to prevent body fat accumulation and obesity-related metabolic diseases.",
keywords = "high fat diet (HFD), kefir peptides, lipid oxidative pathway, lipogenesis, obesity, oxidative damage",
author = "Tung, {Yu Tang} and Chen, {Hsiao Ling} and Wu, {Hsin Shan} and Ho, {Mei Hsuan} and Chong, {Kowit Yu} and Chen, {Chuan Mu}",
year = "2018",
month = "2",
day = "1",
doi = "10.1002/mnfr.201700505",
language = "English",
volume = "62",
journal = "Molecular Nutrition and Food Research",
issn = "1613-4125",
publisher = "Wiley-VCH Verlag",
number = "3",

}

TY - JOUR

T1 - Kefir Peptides Prevent Hyperlipidemia and Obesity in High-Fat-Diet-Induced Obese Rats via Lipid Metabolism Modulation

AU - Tung, Yu Tang

AU - Chen, Hsiao Ling

AU - Wu, Hsin Shan

AU - Ho, Mei Hsuan

AU - Chong, Kowit Yu

AU - Chen, Chuan Mu

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Scope: Obesity has reached epidemic proportions worldwide. Obesity is a complex metabolic disorder that is linked to numerous serious health complications with high morbidity. The present study evaluated the effects of kefir peptides on high fat diet (HFD)-induced obesity in rats. Methods and results: Kefir peptides markedly improved obesity, including body weight gain, inflammatory reactions and the formation of adipose tissue fat deposits around the epididymis and kidney, and adipocyte size. Treating high fat diet (HFD)-induced obese rats with kefir peptides significantly reduced the fatty acid synthase protein and increased the p-acetyl-CoA carboxylase protein to block lipogenesis in the livers. Kefir peptides also increased fatty acid oxidation by increasing the protein expressions of phosphorylated AMP-activated protein kinase, peroxisome proliferator-activated receptor-α, and hepatic carnitine palmitoyltransferase-1 in the livers. In addition, administration of kefir peptides significantly decreased the inflammatory response (TNF-α, IL-1β, and TGF-β) to modulate oxidative damage. Conclusion: These results demonstrate that kefir peptides treatment improves obesity via inhibition of lipogenesis, modulation of oxidative damage, and stimulation of lipid oxidation. Therefore, kefir peptides may act as an anti-obesity agent to prevent body fat accumulation and obesity-related metabolic diseases.

AB - Scope: Obesity has reached epidemic proportions worldwide. Obesity is a complex metabolic disorder that is linked to numerous serious health complications with high morbidity. The present study evaluated the effects of kefir peptides on high fat diet (HFD)-induced obesity in rats. Methods and results: Kefir peptides markedly improved obesity, including body weight gain, inflammatory reactions and the formation of adipose tissue fat deposits around the epididymis and kidney, and adipocyte size. Treating high fat diet (HFD)-induced obese rats with kefir peptides significantly reduced the fatty acid synthase protein and increased the p-acetyl-CoA carboxylase protein to block lipogenesis in the livers. Kefir peptides also increased fatty acid oxidation by increasing the protein expressions of phosphorylated AMP-activated protein kinase, peroxisome proliferator-activated receptor-α, and hepatic carnitine palmitoyltransferase-1 in the livers. In addition, administration of kefir peptides significantly decreased the inflammatory response (TNF-α, IL-1β, and TGF-β) to modulate oxidative damage. Conclusion: These results demonstrate that kefir peptides treatment improves obesity via inhibition of lipogenesis, modulation of oxidative damage, and stimulation of lipid oxidation. Therefore, kefir peptides may act as an anti-obesity agent to prevent body fat accumulation and obesity-related metabolic diseases.

KW - high fat diet (HFD)

KW - kefir peptides

KW - lipid oxidative pathway

KW - lipogenesis

KW - obesity

KW - oxidative damage

UR - http://www.scopus.com/inward/record.url?scp=85039778584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039778584&partnerID=8YFLogxK

U2 - 10.1002/mnfr.201700505

DO - 10.1002/mnfr.201700505

M3 - Article

AN - SCOPUS:85039778584

VL - 62

JO - Molecular Nutrition and Food Research

JF - Molecular Nutrition and Food Research

SN - 1613-4125

IS - 3

M1 - 1700505

ER -